Pharmaceutical

‘Falling through the cracks’: Why ADHD is under-diagnos...

Researchers and mental health professionals say there's a dearth of research and...

Opinion: Cancer drug shortages should have patients rio...

The economics of manufacturing generic drugs are broken.

Opinion: How to separate sound wellness solutions from ...

Consumers, regulators, academia, and industry all have a pivotal role to play in...

Bio-Thera and Biomm enter licensing deal for ustekinuma...

BAT2206 received approval as a monotherapy or along with methotrexate to treat a...

Coherus BioSciences to acquire Surface Oncology for $65m

The deal will add Surface Oncology’s clinical stage assets, SRF388 and SFR114, t...

Cholesgen and AstraZeneca to advance research in hyperc...

The partnership will focus on selected targets from Cholesgen's early stage port...

Rosemont expands liquid medicine portfolio with Lucis a...

Rosemont is targeting the single-use sachet market, shaping its decision to acqu...

FDA extends review of GSK’s myelofibrosis drug

The FDA extends the review period for GSK’s Sierra Oncology myelofibrosis drug m...

China approves Medivir’s patent application for Fostrox

Medivir has already received patents for Fostrox in the EU, Japan, the US and a ...

Overcoming regulatory issues with investigational medic...

For clinical trials operating across different counties, challenges with regulat...

Laurus Labs and IIT Kanpur partner for new gene therapy...

Laurus Labs will establish a GMP facility at IIT Kanpur’s Techno Park facility.

STAT+: A chatbot that’s cautious about GPT, AI pronounc...

In the latest edition of STAT's Health Tech newsletter: a chatbot that's cautiou...

FDA approves Biostar’s Phase II/III plans with utidelon...

The company hopes to work with other partners to bring Utidelone to market.

Abu Dhabi DoH signs new deal to accelerate development ...

The deal will see expansion of research into genomic medicine and genetic diseases.

Verix boosts life science AI capabilities with start-up...

start-up.ai will be merged with Verix’s AI lab, and its co-founder and CEO Shaha...

FDA clears Genentech’s Columvi for adults with R/R DLBCL

Columvi is a CD20xCD3 T-cell engaging bispecific antibody designed to treat R/R ...